Axxima Pharmaceuticals Overview
- Year Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$17.8M
- Investors
-
1
Axxima Pharmaceuticals General Information
Description
Developer of antibiotic and antiviral drugs. The company develops small molecule compounds that block signal transduction pathways required by pathogens for their survival.
Contact Information
Website
www.axxima.comCorporate Office
- Am Klopfersitz 19
- Martinsried
- 82152 Munich
- Germany
Corporate Office
- Am Klopfersitz 19
- Martinsried
- 82152 Munich
- Germany
Axxima Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 02-Mar-2005 | $17.8M | Completed | Bankruptcy: Admin/Reorg | ||
| 6. Bankruptcy: Admin/Reorg | 01-Dec-2004 | Completed | Bankruptcy: Admin/Reorg | |||
| 5. Later Stage VC (Series D) | 01-Jun-2004 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 19-Dec-2001 | Completed | Product Development | |||
| 3. Grant | 22-May-2001 | Completed | Product Development | |||
| 2. Early Stage VC | Completed | Product Development | ||||
| 1. Early Stage VC | Completed | Product Development |
Axxima Pharmaceuticals Patents
Axxima Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20080194574-A1 | Immunology diseases; autoimmune diseases; prion diseases; ipolar disorders; antiinflammatory agents; trnasplant rejection; antidiabetic agents; viricide against herpes virus, cytomegalo virus | Inactive | 19-Dec-2003 | ||
| WO-2005058876-A1 | Pyrazine derivatives as effective compounds against infectious diseases | Inactive | 16-Dec-2003 | ||
| WO-2005040125-A1 | Quinazoline derivatives for the treatment of herpesviral infections | Inactive | 06-Oct-2003 | ||
| WO-2005026129-A1 | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases | Inactive | 15-Sep-2003 | ||
| WO-2005023818-A2 | Heterobicyclic compounds as pharmaceutically active agents | Inactive | 10-Sep-2003 | C07D409/12 |
Axxima Pharmaceuticals Signals
Axxima Pharmaceuticals Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bear Stearns Health InnoVentures Management | Venture Capital | Minority | ||
| HBM Healthcare Investments | Venture Capital | Minority | ||
| Heidelberg Innovation Fonds Management | Venture Capital | Minority | ||
| LBBW Venture Capital | Corporate Venture Capital | Minority | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority |
Axxima Pharmaceuticals FAQs
-
When was Axxima Pharmaceuticals founded?
Axxima Pharmaceuticals was founded in 1998.
-
Where is Axxima Pharmaceuticals headquartered?
Axxima Pharmaceuticals is headquartered in Munich, Germany.
-
What is the size of Axxima Pharmaceuticals?
Axxima Pharmaceuticals has 20 total employees.
-
What industry is Axxima Pharmaceuticals in?
Axxima Pharmaceuticals’s primary industry is Consulting Services (B2B).
-
Is Axxima Pharmaceuticals a private or public company?
Axxima Pharmaceuticals is a Private company.
-
What is the current valuation of Axxima Pharmaceuticals?
The current valuation of Axxima Pharmaceuticals is .
-
What is Axxima Pharmaceuticals’s current revenue?
The current revenue for Axxima Pharmaceuticals is .
-
How much funding has Axxima Pharmaceuticals raised over time?
Axxima Pharmaceuticals has raised $41.8M.
-
Who are Axxima Pharmaceuticals’s investors?
Bear Stearns Health InnoVentures Management, HBM Healthcare Investments, Heidelberg Innovation Fonds Management, LBBW Venture Capital, and Novartis Venture Fund are 5 of 9 investors who have invested in Axxima Pharmaceuticals.
-
When was Axxima Pharmaceuticals acquired?
Axxima Pharmaceuticals was acquired on 02-Mar-2005.
-
Who acquired Axxima Pharmaceuticals?
Axxima Pharmaceuticals was acquired by GPC Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process